Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
-
Enovix Announces Second Quarter 2025 Financial Results
-
YSX TECH. CO., LTD Announces Financial Results for Fiscal Year 2025
-
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
-
NCS Multistage Holdings, Inc. Announces Second Quarter 2025 Results
-
iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market
-
AppFolio, Inc. Announces Second Quarter 2025 Financial Results
-
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Bimini Capital Management Announces Second Quarter 2025 Results
-
AppFolio Names Tim Eaton as Chief Financial Officer
-
Hub Group Reports Second Quarter 2025 Results
-
Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025
-
Great Elm Group Announces Strategic Partnership with Kennedy Lewis Investment Management
-
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
-
Hydrofarm Holdings Group, Inc. to Announce Second Quarter 2025 Results on August 12, 2025
-
El Pollo Loco Holdings, Inc. Announces Second Quarter 2025 Financial Results
-
GSI Technology, Inc. Announces First Quarter Fiscal 2026 Results
-
SPX Reports Second Quarter 2025 Results
-
Cavco Industries Reports Fiscal 2026 First Quarter Results
-
Horizon Bank Announces Appointment of Senior Vice President, Director of Marketing, John D. Hatfield
-
Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
-
Nature's Sunshine Reports Second Quarter 2025 Results
-
CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025
-
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
-
Sow Good to Hold Second Quarter 2025 Conference Call on Thursday, August 14, 2025, at 10:00 a.m. ET
-
LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia
-
Navitas Powers Xiaomi’s Next Generation GaN Charger
-
LPL Financial Announces Second Quarter 2025 Results
-
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
-
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025
-
Nature's Sunshine Reports Second Quarter 2025 Results
-
Cemtrex Acquires $1 Million in Solana, Citing Structural Mispricing; Targets $10 Million Crypto Treasury Reserve
-
Exponent Declares Regular Quarterly Dividend for Q3 2025
-
Exponent Reports Second Quarter 2025 Financial Results
-
Safety Shot Appoints Markita Russell as Chief Financial Officer
-
Stryker reports second quarter 2025 operating results
-
Rackspace Receives SBTi Approval for Net-Zero Targets, Reinforcing Commitment to Sustainable Operations and Innovation
-
Avista Makes Annual Price Adjustment Filings in Idaho
-
Fidus Investment Corporation Schedules Second Quarter 2025 Earnings Release and Conference Call
-
iRhythm Technologies Announces Second Quarter 2025 Financial Results
-
Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call
-
Shenandoah Telecommunications Company Reports Second Quarter 2025 Results
-
4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update
-
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
-
Zoom to Release Financial Results for the Second Quarter of Fiscal Year 2026
-
Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025
-
zSpace Announces Second Quarter 2025 Earnings and Conference Call Information
-
Synergy CHC Corp. Announces Second Quarter 2025 Earnings and Conference Call Information
-
NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering
-
Orchestra BioMed Announces Proposed Public Offering
